Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab IV in Rheumatoid Arthritis
NCT07704580Phase 2Recruiting
- Sponsor
- Sanofi
- Start
- Jul 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 2 trial of sarilumab in rheumatoid arthritis (RA), sponsored by Sanofi. Started Jul 2026; status: recruiting.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07704580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07704580.